Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes.
about
Harnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesisSILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrinNovel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor-targeting ultrasonic imaging.Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup.Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers.Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in MiceEpigenetic suppression of neprilysin regulates breast cancer invasionImmunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospectsControl of endothelin-a receptor expression by progesterone is enhanced by synergy with Gata2.Cellular iron metabolism in prognosis and therapy of breast cancer.Cystatin C and lactoferrin concentrations in biological fluids as possible prognostic factors in eye tumor development.Protection Against Dimethylbenz[a] Anthracene-Induced Breast Cancer in Female Rats by α-Lactalbumin.Role of inflammatory infiltrates in triple negative breast cancer.Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1.
P2860
Q26861766-0DF60099-D186-4742-9098-29FF41F8EAEBQ28541808-EB9E329D-7FB9-4DA8-A115-FDE19C0A6A08Q30402602-AD027D87-AD20-4C51-95A1-9C7390C72805Q33684982-CFB9EE60-6087-479E-B939-5B893FF84C56Q36355626-2FD50723-0E19-4691-BBC8-8F41C111A783Q36657607-EE466754-CB60-4C24-83CE-BAD50A2AF1A9Q36748694-B0B5B4EC-9EBA-4DFB-9C5C-E84C1026A6C6Q36778827-BCB3483C-A60A-47BD-99BD-532E46031E3CQ36850156-442C4112-AAA0-4DFE-B828-D66430AC5793Q37077422-20D91620-FF9A-4131-BB60-F15AF53545A5Q37120573-6BE451C8-6073-4F41-B213-E21B4BFE2CA5Q37161407-E7156ED0-1B7A-4F25-9C54-66F080C6DBF5Q38370266-959756AC-8CC0-4DE9-BEB1-7359CB53AECFQ38942781-31E14517-3247-405E-A630-A9CE1A30274BQ47098389-1BA720F9-11DB-47DC-B31F-B7156CAFF247
P2860
Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Lactoferrin-endothelin-1 axis ...... tive breast cancer phenotypes.
@ast
Lactoferrin-endothelin-1 axis ...... tive breast cancer phenotypes.
@en
type
label
Lactoferrin-endothelin-1 axis ...... tive breast cancer phenotypes.
@ast
Lactoferrin-endothelin-1 axis ...... tive breast cancer phenotypes.
@en
prefLabel
Lactoferrin-endothelin-1 axis ...... tive breast cancer phenotypes.
@ast
Lactoferrin-endothelin-1 axis ...... tive breast cancer phenotypes.
@en
P2093
P2860
P1433
P1476
Lactoferrin-endothelin-1 axis ...... tive breast cancer phenotypes.
@en
P2093
Allan Lipton
Da-Qiang Li
Divijendra Natha Sirigiri Reddy
George C Prendergast
Kazufumi Ohshiro
Krishna Sumanth Ghanta
Luis Costa
Margaretha Wallon
Ngoc-Han Ha
Prakriti Mudvari
P2860
P304
P356
10.1158/0008-5472.CAN-11-1143
P407
P577
2011-10-17T00:00:00Z